About GLYCART biotechnology
GLYCART’s mission is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs and to be an antibody engineering power-house within the Roche Group.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of GLYCART biotechnology
Similar companies
News about GLYCART biotechnology
Here you will find GLYCART biotechnology AG
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
